These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3135216)

  • 1. Spontaneous and interferon-induced natural cytotoxicity in Crohn's disease.
    Müller C; Knoflach P; Smetana P; Meisinger V; Zielinski CC
    Digestion; 1988; 39(1):26-34. PubMed ID: 3135216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological studies on Crohn's disease. IV. Decreased ADCC activity.
    Okabe N; Fujita K; Takenaka K; Yao T
    J Clin Lab Immunol; 1986 Feb; 19(2):77-81. PubMed ID: 3485720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with adult T-cell leukemia.
    Uno H; Kawano K; Matsuoka H; Tsuda K
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):730-9. PubMed ID: 2618548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
    Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
    J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease].
    Lozano Polo JL; Echevarría Vierna S; Casafont Morencos F; Ledesma Castaño F; Pons Romero F
    Rev Esp Enferm Dig; 1990 Aug; 78(2):71-5. PubMed ID: 2271297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies on Crohn's disease. III. Defective natural killer activity.
    Okabe N; Fujita K; Yao T
    J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients.
    Giacomelli R; Passacantando A; Frieri G; Parzanese I; D'Alò S; Vernia P; Pimpo MT; Petrucci C; Caprilli R; Cifone MG; Tonietti G
    Clin Exp Immunol; 1999 Jan; 115(1):72-7. PubMed ID: 9933422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.
    Auer IO; Ziemer E; Sommer H
    Clin Exp Immunol; 1980 Oct; 42(1):41-9. PubMed ID: 7460390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn's disease through affecting the ADCC activity.
    Moroi R; Endo K; Kinouchi Y; Shiga H; Kakuta Y; Kuroha M; Kanazawa Y; Shimodaira Y; Horiuchi T; Takahashi S; Shimosegawa T
    Immunogenetics; 2013 Apr; 65(4):265-71. PubMed ID: 23358932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and clinical effects of interferon-gamma on Crohn's disease.
    Yoshida T; Higa A; Sakamoto H; Daimon Y; Ohashi T; Haraguchi Y; Tanaka K
    J Clin Lab Immunol; 1988 Mar; 25(3):105-8. PubMed ID: 3135410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis].
    Müller C; Zielinski CC
    Acta Med Austriaca; 1987; 14(5):115-8. PubMed ID: 3125713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome.
    Kerndrup G; Meyer K; Ellegaard J; Hokland P
    Leuk Res; 1984; 8(2):239-47. PubMed ID: 6717064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cortisol and ACTH on corticosteroid-suppressed peripheral blood natural killer cells from healthy volunteers and patients with Crohn's disease.
    van Ierssel GJ; Mieremet-Ooms MA; van der Zon AM; van Hogezand RA; Wagtmans MJ; van der Sluys Veer A; Lamers CB; Verspaget HW
    Immunopharmacology; 1996 Sep; 34(2-3):97-104. PubMed ID: 8886853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
    Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
    Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
    Sung MW; Johnson JT; Van Dongen G; Whiteside TL
    Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lytic effector cell function in schizophrenia and depression.
    Urch A; Müller C; Aschauer H; Resch F; Zielinski CC
    J Neuroimmunol; 1988 Jul; 18(4):291-301. PubMed ID: 2898486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood.
    Auer IO; Ziemer E
    Klin Wochenschr; 1980 Aug; 58(15):779-87. PubMed ID: 7442085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.